← Leaderboards
Jie Jiang
Ludwig Institute For Cancer Res Ltd
$2,738,745
Attributed
$3,540,650
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $820.4K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,540,650 · 5
By mechanism
R01$2,559,397 · 2
R21$927,971 · 2
F32$53,282 · 1
Top collaborators
- Gary J Bassell3 shared
- Zhaohui Steve Qin2 shared
- Matthew J.M. Rowan1 shared
Most similar at Ludwig Institute For Cancer Res Ltd
Same institution · by research overlap
- Shuying Sun$11,240,869
Others in their field
Top investigators on “Pathologic”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologicPathogenesisGeneticNeurodegenerative DisordersNeuronsGenesPlayGain Of FunctionTransgenic MiceC9orf72Toxic EffectPathogenicityPathologyCellsPathway InteractionsNeuron LossDipeptidesProteinsLoss Of FunctionPhenotypeMolecularAntisense OligonucleotidesMediatingProduction
Grant awards (12)
Pathogenic mechanisms of KIF5A-associated ALS$532,381
R01 · FY2025 · NS · contact PI
Cell-type-specific toxicity of C9orf72 repeat expansions in FTD and ALS$390,000
R01 · FY2024 · AG · contact PI
Cell-type-specific toxicity of C9orf72 repeat expansions in FTD and ALS$77,016
R01 · FY2024 · AG · contact PI
Mechanistic insights of cortical hyperexcitability in ALS$75,699
R21 · FY2024 · NS · contact PI
Mechanistic insights of cortical hyperexcitability in ALS$430,375
R21 · FY2023 · NS · contact PI
Cell-type-specific toxicity of C9orf72 repeat expansions in FTD and ALS$390,000
R01 · FY2023 · AG · contact PI
Cell-type-specific toxicity of C9orf72 repeat expansions in FTD and ALS$390,000
R01 · FY2022 · AG · contact PI
Cell-type-specific toxicity of C9orf72 repeat expansions in FTD and ALS$390,000
R01 · FY2021 · AG · contact PI
Cell-type-specific toxicity of C9orf72 repeat expansions in FTD and ALS$390,000
R01 · FY2020 · AG · contact PI
Mechanistic insight into RNA-mediated toxicity of C9orf72-linked ALS/FTD$191,279
R21 · FY2020 · NS
Mechanistic insight into RNA-mediated toxicity of C9orf72-linked ALS/FTD$230,618
R21 · FY2019 · NS
Pathogenic mechanisms of C9orf72 GGGGCC repeat expansions in amyotrophic lateral sclerosis and frontotemporaldementia and development of therapeutic strategies$53,282
F32 · FY2014 · NS · contact PI